Wpd Pharmaceuticals Stock Performance
The firm maintains a market beta of 0.0, which attests to not very significant fluctuations relative to the market. the returns on MARKET and WPD Pharmaceuticals are completely uncorrelated.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days WPD Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, WPD Pharmaceuticals is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
| Begin Period Cash Flow | 3 M | |
| Total Cashflows From Investing Activities | -645.5 K |
WPD |
WPD Pharmaceuticals Relative Risk vs. Return Landscape
If you would invest 0.00 in WPD Pharmaceuticals on October 16, 2025 and sell it today you would earn a total of 0.00 from holding WPD Pharmaceuticals or generate 0.0% return on investment over 90 days. WPD Pharmaceuticals is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded pink sheets are less volatile than WPD, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
WPD Pharmaceuticals Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for WPD Pharmaceuticals' investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as WPD Pharmaceuticals, and traders can use it to determine the average amount a WPD Pharmaceuticals' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| High Returns | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| WPDPF |
Based on monthly moving average WPD Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of WPD Pharmaceuticals by adding WPD Pharmaceuticals to a well-diversified portfolio.
WPD Pharmaceuticals Fundamentals Growth
WPD Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of WPD Pharmaceuticals, and WPD Pharmaceuticals fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on WPD Pink Sheet performance.
| Return On Equity | -21.8 | |||
| Return On Asset | -1.29 | |||
| Current Valuation | (221 K) | |||
| Shares Outstanding | 113.44 M | |||
| Price To Book | 107.84 X | |||
| EBITDA | (6.03 M) | |||
| Cash And Equivalents | 637.59 K | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 306.19 K | |||
| Debt To Equity | 2.15 % | |||
| Book Value Per Share | (0.02) X | |||
| Cash Flow From Operations | (1.38 M) | |||
| Earnings Per Share | (0.03) X | |||
| Total Asset | 2.68 M | |||
About WPD Pharmaceuticals Performance
By analyzing WPD Pharmaceuticals' fundamental ratios, stakeholders can gain valuable insights into WPD Pharmaceuticals' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if WPD Pharmaceuticals has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if WPD Pharmaceuticals has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
WPD Pharmaceuticals Inc. engages in the research and development of medicinal products in the fields of oncology and infectious diseases. WPD Pharmaceuticals Inc. is headquartered in Vancouver, Canada. Wpd Pharmaceuticals operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 19 people.Things to note about WPD Pharmaceuticals performance evaluation
Checking the ongoing alerts about WPD Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for WPD Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| WPD Pharmaceuticals generated a negative expected return over the last 90 days | |
| WPD Pharmaceuticals has some characteristics of a very speculative penny stock | |
| WPD Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| WPD Pharmaceuticals has accumulated 306.19 K in total debt with debt to equity ratio (D/E) of 2.15, implying the company greatly relies on financing operations through barrowing. WPD Pharmaceuticals has a current ratio of 0.39, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist WPD Pharmaceuticals until it has trouble settling it off, either with new capital or with free cash flow. So, WPD Pharmaceuticals' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like WPD Pharmaceuticals sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for WPD to invest in growth at high rates of return. When we think about WPD Pharmaceuticals' use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (7.52 M) with loss before overhead, payroll, taxes, and interest of (107.72 K). | |
| WPD Pharmaceuticals has accumulated about 637.59 K in cash with (1.38 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01. | |
| Roughly 40.0% of WPD Pharmaceuticals outstanding shares are owned by insiders |
- Analyzing WPD Pharmaceuticals' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether WPD Pharmaceuticals' stock is overvalued or undervalued compared to its peers.
- Examining WPD Pharmaceuticals' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating WPD Pharmaceuticals' management team can have a significant impact on its success or failure. Reviewing the track record and experience of WPD Pharmaceuticals' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of WPD Pharmaceuticals' pink sheet. These opinions can provide insight into WPD Pharmaceuticals' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for WPD Pink Sheet analysis
When running WPD Pharmaceuticals' price analysis, check to measure WPD Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy WPD Pharmaceuticals is operating at the current time. Most of WPD Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of WPD Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move WPD Pharmaceuticals' price. Additionally, you may evaluate how the addition of WPD Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |